2023 The Final Countdown, page-785

Roche Holding AG
(RHHBY)

Glofitamab (BLA)

07/01/2023

Eisai Co Ltd
(ESALY.PK)

LEQEMBI (sBLA)

07/06/2023

Biogen Inc.
(BIIB)

LEQEMBI (sBLA)

07/06/2023

Verrica Pharmaceuticals Inc.
(VRCA)

VP-102 (Resubmitted NDA)

07/23/2023

Daiichi Sankyo Company Limited
(DSKYF.PK)

Quizartinib (NDA)

07/24/2023

Citius Pharmaceuticals, Inc.
(CTXR)

I/ONTAK (BLA)

07/28/2023

Mesoblast Limited
(MESO)

Remestemcel-L (Resubmitted BLA)

08/02/2023

From next week these are the approval dates for those ahead of us. There are a couple of others with date ranges such as August or Late August.

Personally I like the big gap between set approval dates of the 6th July and 23rd July.

That's my sweet spot for an early approval, I can dream


Reg